Cellcarta

Call
Website
1841 Centre Point Cir
Naperville, IL 60563
+1 (630) 703-2098
https://cellcarta.com

CellCarta is a global leader in biomarker solutions, offering a comprehensive suite of services that include clinical biomarkers discovery, preclinical services, and advanced genomic and proteomic analysis. With expertise in immune monitoring and histopathology, they provide cutting-edge technologies and support across various therapeutic areas, including oncology and immunology.

The company specializes in innovative methodologies such as digital PCR, single-cell sequencing, and flow cytometry, alongside robust bioinformatics and regulatory expertise. With locations across North America, Europe, Australia, and Asia, CellCarta is committed to enhancing research and clinical outcomes through its thorough quality management systems and laboratory services.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Colleges and universities

IMCA-CAT at University of Chicago

IMCA-CAT at University of Chicago in Lemont, IL is a research facility specializing in advanced materials characterization and analysis. The facility offers state-of-the-art equipment and expertise to support a wide range of research projects in various scientific disciplines. Generated from their business information
Internal medicine practitioners, Market analysis, business, and economic research, Civic associations

Knee Society

The Knee Society, based in Schaumburg, IL, is a professional organization dedicated to advancing the field of knee surgery and research. With a focus on education, collaboration, and innovation, the society brings together medical professionals to share knowledge and best practices in knee-related healthcare. Generated from their business information

CDG Therapeutics Inc

CDG Therapeutics Inc. is a biotechnology company based in Chicago, specializing in the development and commercialization of proprietary peptides derived from both pathogenic and nonpathogenic bacteria and green plants. These innovative peptides are designed to selectively enter cancer cells, inducing cell cycle arrest and leading to cell death. The company's focus on harnessing the unique properties of these peptides positions it at the forefront of cancer therapy research, contributing to advancements in treatment options. Through its commitment to science and technology, CDG Therapeutics aims to make significant strides in the fight against cancer. Generated from the website
United States›Illinois›Naperville›Cellcarta

Partial Data by Infogroup (c) 2024. All rights reserved.